AJP - Endo Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 281: E655-E664, 2001;
0193-1849/01 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via ISI Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mei, Q.
Right arrow Articles by Taborsky, G. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mei, Q.
Right arrow Articles by Taborsky, G. J., Jr.
Vol. 281, Issue 4, E655-E664, October 2001

Fos expression in rat celiac ganglion: an index of the activation of postganglionic sympathetic nerves

Qi Mei, Thomas O. Mundinger, David Kung, Denis G. Baskin, and Gerald J. Taborsky Jr.

Division of Endocrinology and Metabolism, Department of Medicine, Veterans Affairs Puget Sound Health Care System, Seattle 98108; and University of Washington, Seattle, Washington 98159

To develop an index of the activation of abdominal sympathetic nerves, we used Fos immunostaining of the celiac ganglion (CG) taken from rats receiving nicotine, preganglionic nerve stimulation, or glucopenic agents. Subcutaneous nicotine injection moderately increased Fos expression in the principal ganglionic cells of the CG (17 ± 4 Fos+ per mm2, ~12% of all principal CG cells), whereas subcutaneous saline had no effect (0 ± 0 Fos+ per mm2; n = 7; P < 0.01). Greater Fos expression was obtained by applying nicotine topically to the CG (71 ± 8 Fos+ per mm2; 52% of all principal CG cells, n = 5; P < 0.01 vs. topical saline, n = 4) and by preganglionic nerve stimulation (126 ± 9 Fos+ per mm2; 94% of all principal CG cells, n = 11; P < 0.01 vs. nerve isolation, n = 7). Moderate Fos expression was also observed in the CG after intraperitoneal 2-deoxy-D-glucose (2DG) injection (21 ± 2 Fos+ per mm2; 16% of all principal CG cells, n = 5; P < 0.01 vs. saline ip) or insulin injection (16 ± 2 Fos+ per mm2; 12% of all principal CG cells, n = 6; P < 0.01 vs. saline ip). Furthermore, Fos expression induced by 2DG was dose and time dependent. These data demonstrate significant Fos expression in the CG in response to chemical, electrical, and reflexive stimulation. Thus Fos expression in the CG may be a useful index to describe various levels of activation of its postganglionic sympathetic neurons.

hypoglycemia; nicotine; nerve stimulation; deoxyglucose; insulin





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online